Ixcells Biotechnologies Secures Strategic Growth Investment From Great Point Partners
Round Type
Venture
San DiegoBiotechnologyTherapeuticsDescription
iXCells Biotechnologies (“iXCells” or the “Company”), a high growth provider of cell-based products and discovery services to the academic, biotech and pharmaceutical communities worldwide, with special focus on primary and induced pluripotent stem cell (“iPSC”) derived cellular models, today announced receiving a growth investment from Connecticut-based Great Point Partners (“GPP”), a private investment firm focusing on the healthcare industry.
Quick answer
iXCells Biotechnologies raised an undisclosed amount in a funding round, dated September 29, 2022. iXCells Biotechnologies is based in San Diego, California, United States.
- How much did iXCells Biotechnologies raise?
- iXCells Biotechnologies raised an undisclosed amount in a funding round on September 29, 2022.
- What does iXCells Biotechnologies do?
- Founded in 2014 and based in San Diego, CA, iXCells Biotechnologies is an innovative cell biology and cell technology company that provides preclinical drug discovery solutions with the focus on disease relevant..
- Where is iXCells Biotechnologies based and how big is it?
- iXCells Biotechnologies is based in San Diego, California, United States.
- Who are the decision-makers at iXCells Biotechnologies?
- Fundz holds 1 contact at iXCells Biotechnologies. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as iXCells Biotechnologies that raised within 45 days of this round, from Fundz verified event records.
- Lipidio Pharmaceuticals raised an undisclosed amount (Series A) on November 10, 2022.
- NRG Therapeutics raised $18M (Series A) on November 9, 2022.
- Kinimmune raised an undisclosed amount (Funding Round) on November 9, 2022.
- Juvena Therapeutics raised $41M (Funding Round) on November 8, 2022.
- NRx Pharmaceuticals raised $11M (Debt Financing) on November 7, 2022.
- Zenas BioPharma raised $118M (Funding Round) on November 7, 2022.
Who to call at iXCells Biotechnologies, and when
A new round usually means iXCells Biotechnologies is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day iXCells Biotechnologies raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at iXCells Biotechnologies, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at iXCells Biotechnologies. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment iXCells Biotechnologies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
iXCells Biotechnologies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.